Scientific and medical writing you can defend in review
PhD-led writing, evidence synthesis and bioinformatics, with documented QC, traceable sources and a named scientist accountable for every deliverable.
- NDA before scoping — mutual confidentiality executed prior to sharing protocols or data
- Documented 6-step QC — line-by-line primary source verification and table-to-text audit
- Named PhD scientist sign-off — direct scientific accountability, never anonymous AI drafting
Why scientific teams replace ad-hoc drafting with accountable PhD execution
Automated text tools have commoditized surface prose, but cannot take scientific, regulatory, or authorship responsibility when a peer reviewer, HTA assessor, or diligence team audits your claims.
Integrated scientific writing, evidence synthesis, and computational biology
Consolidated around the deliverables that move clinical, biotech, and academic programmes through peer review, HTA appraisal, and R&D milestones.
Medical & Scientific Writing
Publication-grade manuscripts, reviews, grant proposals, and clinical documentation written by PhD scientists with first- and senior-author track records.
Evidence Synthesis & HTA
Methodologically rigorous systematic reviews, meta-analyses, and certainty assessments built to withstand Cochrane, journal, and reimbursement scrutiny.
Computational Biology
Writers who can run, audit, and reproduce the underlying bioinformatics — bridging wet-lab datasets and high-impact translational narratives.
Tailored scientific support for industry and academic teams
Pharma & CROs
PRISMA 2020 systematic reviews, GRADE evidence profiles, HTA dossier modules, clinical publications, and ICH-aligned regulatory documentation with documented QC.
Biotech & Startups
Multi-omics biomarker discovery, scRNA-seq target validation, non-dilutive grant strategy (IRAP / NIH SBIR / CIHR), and diligence-ready technical white papers.
Academic Researchers
End-to-end bioinformatics pipelines, publication-grade figures, manuscript architecture, and point-by-point peer-review response letters under ICMJE standards.
Selected case studies & founder research benchmarks
PRISMA 2020 Systematic Review & GRADE Appraisal in Obstetrics
12–14 week end-to-end systematic review for a clinician-investigator: Cochrane-standard search strings, blinded dual screening in Rayyan, RoB 2 appraisal, and GRADE certainty profiles. Client retained first/senior authorship per ICMJE guidelines.
Cross-Species Single-Cell RNA-Seq for Neuroscience Target Discovery
8–10 week bioinformatics and translational writing engagement for a neuroscience group: batch-corrected cross-species scRNA-seq integration, conserved cell-state target prioritization, and grant-ready figures delivered ahead of deadline.
iTRAQ Quantitative Proteomics & Complement Inhibition in Arthritis
Multi-institution academic research led by Dr. Debasis Sahu (First Author) across NII, ICGEB, JNU, and NYU (Front. Cell Dev. Biol. 2022;10:845457), demonstrating our leadership team's hands-on mastery of quantitative proteomics and pathway pharmacology.
Selected publications by our founding scientific leadership
Verified against PubMed, ORCID (0000-0003-1720-2680), and Google Scholar.
Computational proteomics to enhance personalized treatment of COVID-19 and Long COVID
Sahu D, Van Nynatten LR, Tweddell D, Daley M, Fraser DD. Clin Proteomics. 2026;23(1):18.
Novel peptide inhibitor of human tumor necrosis factor-α has antiarthritic activity
Sahu D, Gupta C, Yennamalli RM, Sharma S, Roy S, Hasan S, Gupta PK, Sharma VK, Kashyap S, Kumar S, Dwivedi VP, Zhao X, Panda AK, Das HR, Liu CJ. Sci Rep. 2024;14(1):12926.
Troxerutin-mediated complement pathway inhibition is a disease-modifying treatment for inflammatory arthritis
Sahu D, Bishwal SC, Malik MZ, Sahu S, Kaushik SR, Sharma S, Saini E, Arya R, Rastogi A, Sharma S, Sen S, Singh RKB, Liu CJ, Nanda RK, Panda AK. Front Cell Dev Biol. 2022;10:845457.
An insight into the therapeutic applications of coumarin compounds and their mechanisms of action
Garg SS, Gupta J, Sharma S, Sahu D. Eur J Pharm Sci. 2020;152:105424.
Where our founding PhD scientists trained and published
The institutions below represent the prior doctoral, postdoctoral, and academic research appointments of our founding leadership (Dr. Debasis Sahu & Dr. Shikha Sharma) and are listed for biographical transparency, not as commercial endorsements.
Ready for scientific writing and analysis you can defend in review?
Scope your manuscript, PRISMA 2020 systematic review, regulatory document, or multi-omics dataset directly with our PhD scientific leadership.
100% confidential · Mutual NDA before scoping · Client owns 100% of deliverables